Tuberculosis in the kidney
Tuberculosis in the kidney
Tuberculosis in the lung
Tuberculosis in the lung
Tuberculosis, advanced - chest X-rays
Tuberculosis, advanced - chest X-rays
Pulmonary nodule - front view chest X-ray
Pulmonary nodule - front view chest X-ray
Pulmonary nodule, solitary - CT scan
Pulmonary nodule, solitary - CT scan
Miliary tuberculosis
Miliary tuberculosis
Tuberculosis of the lungs
Tuberculosis of the lungs
Erythema nodosum associated with sarcoidosis
Erythema nodosum associated with sarcoidosis
Respiratory system
Respiratory system


Pulmonary tuberculosis

Alternative Names:
TB; Tuberculosis - pulmonary; Consumption 

Treatment:
The goal of treatment is to cure the infection with antitubercular drugs. Daily oral doses of multiple drugs that may include combinations of rifampin, isoniazid, pyrazinamide, ethambutol, or occasionally others, are continued until culture results (if available) showing the drug sensitivity of the mycobacterial infection help to guide the selection of drugs. 

Treatment is typically continued for 6 months, but longer courses may be required for AIDS patients or those whose disease responds slowly. For atypical tuberculosis infections, or drug-resistant strains, other drugs and different durations of therapy may be indicated to treat the infection.

Hospitalization may be indicated to prevent the spread of the disease to others until the contagious period has resolved on drug therapy. Normal activity can be continued after the contagious period.



Support Groups:

The stress of illness can often be helped by joining a support group where members share common experiences and problems. See lung disease - support group.



Expectations (prognosis):

Symptoms may improve in 2 to 3 weeks, with improvement seen in the chest X-ray lagging behind clinical improvement. Prognosis is excellent if pulmonary TB is diagnosed early and treatment is begun.



Complications:

Pulmonary TB can cause permanent lung damage if not treated early.

All medications used to treat TB have some toxicity. Rifampin and isoniazid may both cause a non-infectious hepatitis. Rifampin may also cause an orange or brown coloration of tears and urine.

Those taking ethambutol should have their vision monitored, as this drug may rarely affect the eye. Any rash, abdominal pain, jaundice, or tingling in toes or fingers may be a sign of drug toxicity and should be reported to your doctor immediately.

Other complications include drug resistance to particular TB strains and a relapse of the disease in some patients.



Calling your health care provider:
Call your health care provider if you have been exposed to tuberculosis, or if symptoms of TB develop.

Call your health care provider if symptoms persist despite treatment.

Also call if new symptoms develop, including indications that complications are developing.




Review Date: 3/6/2002
Reviewed By: Darrell N. Kotton, M.D., Division of Pulmonary and Critical Care, Boston University School of Medicine, Boston, MA. Review provided by VeriMed Healthcare Network.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.